NEW YORK (GenomeWeb) – NTD Eurofins, a subsidiary of Eurofins Scientific, has received approval from the New York State Department of Health to add Y chromosome assessment to an already-approved noninvasive prenatal screening test.

The assessment for the presence of Y chromosome DNA in maternal serum uses real-time PCR technology, which the firm said enables it to provide a more personalized risk assessment as early as 10 weeks' gestation.